Drug Profile
Anthrax vaccine adsorbed (BioThrax) - Emergent BioSolutions
Alternative Names: Anthrax vaccine adsorbed (AVA) - Emergent BioSoutions; AVA; BaciThrax; BioThraxLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Emergent BioSolutions
- Class Anthrax vaccines
- Mechanism of Action Anthrax toxin modulators; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Anthrax
Most Recent Events
- 17 Dec 2018 Registered for Anthrax (Prevention) in Canada (IM)
- 21 Apr 2018 Adverse events data from a phase II trial in Anthrax presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID-2018)
- 12 Apr 2018 Preregistration (Mutual Recognition Procedure) for Anthrax (Prevention) in France, United Kingdom, Poland, Netherlands, Italy (IM)